Last quarter (Q3 2024), Hemostemix's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Hemostemix's net income was $-314.56K. See Hemostemix’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 1.08M	$ 2.16M	$ 4.63M	$ 6.66M	$ 7.47M	$ 4.70M
Operating Income	$ -1.08M	$ -2.16M	$ -4.63M	$ -6.66M	$ -7.47M	$ -4.70M
Net Non Operating Interest Income Expense	$ -681.90K	$ -556.12K	$ -306.20K	$ 20.85K	$ 113.03K	$ 104.98K
Other Income Expense	$ 134.83K	$ -194.80K	$ -2.21K	$ 135.17K	$ -189.11K	$ -68.64K
Pretax Income	$ -1.99M	$ -2.50M	$ -4.75M	$ -6.54M	$ -7.77M	$ -4.87M
Tax Provision	$ ―	$ ―	$ ―	$ -255.78K	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -1.99M	$ -2.50M	$ -4.75M	$ -6.29M	$ -7.77M	$ -4.87M
Basic EPS	$ -0.03	$ -0.03	$ -0.07	$ -0.11	$ -0.24	$ -6.40
Diluted EPS	$ -0.03	$ -0.03	$ -0.07	$ -0.11	$ -0.24	$ -6.40
Basic Average Shares	$ 349.85M	$ 82.50M	$ 69.98M	$ 57.45M	$ 32.24M	$ 752.25K
Diluted Average Shares	$ 349.85M	$ 82.50M	$ 69.98M	$ 57.45M	$ 32.24M	$ 752.25K
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 442.59K	$ ―	$ 4.63M	$ -6.66M	$ -7.47M	$ -4.70M
Net Income From Continuing And Discontinued Operation	$ -1.99M	$ -2.50M	$ -4.75M	$ -6.29M	$ -7.77M	$ -4.87M
Normalized Income	$ -1.80M	$ -1.84M	$ -3.49M	$ -6.80M	$ -5.63M	$ -3.58M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -1.31M	$ -1.95M	$ -4.44M	$ -6.53M	$ -7.66M	$ -4.76M
EBITDA	$ -1.31M	$ -1.95M	$ -4.44M	$ -6.53M	$ -7.66M	$ -4.76M

Currency in USD

Hemostemix Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing